ArcticZymes Technologies ASA Share Price

Equities

AZT

NO0010014632

Biotechnology & Medical Research

Market Closed - Oslo Bors 15:45:00 29/04/2024 BST 5-day change 1st Jan Change
25.9 NOK -0.38% Intraday chart for ArcticZymes Technologies ASA -0.96% -38.33%

Financials

Sales 2023 119M 10.81M 861M Sales 2024 * 127M 11.57M 922M Capitalization 1.32B 120M 9.54B
Net income 2023 18M 1.64M 130M Net income 2024 * 19M 1.73M 138M EV / Sales 2023 16.5 x
Net cash position 2023 168M 15.3M 1.22B Net cash position 2024 * 191M 17.34M 1.38B EV / Sales 2024 * 8.85 x
P/E ratio 2023
114 x
P/E ratio 2024 *
66.1 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 70.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.38%
1 week-0.96%
Current month-11.75%
1 month-11.75%
3 months-35.89%
6 months-3.36%
Current year-38.33%
More quotes
1 week
25.05
Extreme 25.05
27.75
1 month
25.05
Extreme 25.05
29.70
Current year
25.05
Extreme 25.05
43.20
1 year
24.20
Extreme 24.2
47.50
3 years
24.20
Extreme 24.2
114.40
5 years
3.52
Extreme 3.52
114.40
10 years
3.50
Extreme 3.5
114.40
More quotes
Managers TitleAgeSince
Chief Executive Officer - 17/09/23
Director of Finance/CFO 49 30/09/14
Chief Tech/Sci/R&D Officer - 30/11/22
Members of the board TitleAgeSince
Chairman - -
Chief Tech/Sci/R&D Officer 52 31/12/99
Chief Operating Officer 56 -
More insiders
Date Price Change Volume
29/04/24 25.9 -0.38% 17,361
26/04/24 26 +0.78% 23,429
25/04/24 25.8 -2.82% 280,397
24/04/24 26.55 +1.14% 18,192
23/04/24 26.25 +0.38% 13,629

Real-time Oslo Bors, April 29, 2024 at 03:45 pm

More quotes
Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
25.9 NOK
Average target price
32 NOK
Spread / Average Target
+23.55%
Consensus